The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(4-formyl-1,3-diphenyl-1H-pyrazol-5-yl)-N,N-diethyl-methanimidamide ID: ALA1270397
PubChem CID: 52945832
Max Phase: Preclinical
Molecular Formula: C21H22N4O
Molecular Weight: 346.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN(/C=N/c1c(C=O)c(-c2ccccc2)nn1-c1ccccc1)CC
Standard InChI: InChI=1S/C21H22N4O/c1-3-24(4-2)16-22-21-19(15-26)20(17-11-7-5-8-12-17)23-25(21)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3/b22-16+
Standard InChI Key: JXYULSUSJGKIJV-CJLVFECKSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.5344 -5.2679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3601 -5.1787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5225 -4.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8175 -3.9691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1989 -4.5262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8146 -3.1416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1013 -2.7259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0987 -1.8975 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4879 -4.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4892 -3.2881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7796 -2.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0615 -3.2889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0617 -4.1130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7760 -4.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7852 -5.8883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3852 -1.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2819 -4.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9519 -4.5262 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8110 -1.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3795 -6.6099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8038 -7.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6318 -7.3060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0334 -6.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6066 -5.8720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3857 -0.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8107 -0.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 15 1 0
2 3 1 0
7 8 1 0
3 4 2 0
5 9 1 0
4 5 1 0
9 10 2 0
8 16 1 0
5 1 1 0
3 17 1 0
10 11 1 0
17 18 2 0
1 2 2 0
8 19 1 0
15 20 2 0
11 12 2 0
20 21 1 0
4 6 1 0
21 22 2 0
12 13 1 0
22 23 1 0
13 14 2 0
23 24 2 0
24 15 1 0
14 9 1 0
16 25 1 0
6 7 2 0
19 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.43Molecular Weight (Monoisotopic): 346.1794AlogP: 4.35#Rotatable Bonds: 7Polar Surface Area: 50.49Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.85CX LogP: 4.21CX LogD: 4.11Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.36Np Likeness Score: -0.79
References 1. Cheng KM, Huang YY, Huang JJ, Kaneko K, Kimura M, Takayama H, Juang SH, Wong FF.. (2010) Synthesis and antiproliferative evaluation of N,N-disubstituted-N'-[1-aryl-1H-pyrazol-5-yl]-methnimidamides., 20 (22): [PMID:20855206 ] [10.1016/j.bmcl.2010.08.133 ]